Smartphone app provides skin cancer early warning serviceThe makers of a smartphone app are hoping that it could be used to play a crucial role Share XSmartphone app provides skin cancer early warning servicehttps://pharmaphorum.com/news/smartphone-app-provides-skin-cancer-early-warning-service/
Almirall gets in on the eczema actionSanofi’s Dupixent has shown there is a market for biologic drugs to treat eczema, and now Spain’s Almirall Share XAlmirall gets in on the eczema actionhttps://pharmaphorum.com/views-analysis-market-access/almirall-gets-in-on-the-eczema-action/
Deep Dive: Access and CommercialisationIn this issue of Deep Dive we explore the ever present issues of market access and commercialisation, analysing Share XDeep Dive: Access and Commercialisationhttps://pharmaphorum.com/digital/pharma-access-commercialisation/
LEO Pharma teams up with Wearifi for dermatology research wearableLEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential Share XLEO Pharma teams up with Wearifi for dermatology research wearablehttps://pharmaphorum.com/news/leo-pharma-wearifi-dermatology/
Almirall buys Allergan’s derma portfolioAlmirall is expanding its business by buying Allergan’s dermatology portfolio. The Spanish pharma company will buy five brands Share XAlmirall buys Allergan’s derma portfoliohttps://pharmaphorum.com/news/almirall-buys-allergans-derma-portfolio/
LEO Pharma acquires Bayer’s dermatology unitDanish LEO Pharma announced yesterday (July 31st) that it has entered a binding agreement to purchase Bayer’s global Share XLEO Pharma acquires Bayer’s dermatology unithttps://pharmaphorum.com/news/leo-pharma-acquires-bayers-dermatology-unit/
The sky’s the limit for LEO Pharma’s R&D hubAs part of pharmaphorum’s eye-on-innovation series of interviews, Richard Staines speaks to Michael Sierra, Vice President of LEO Share XThe sky’s the limit for LEO Pharma’s R&D hubhttps://pharmaphorum.com/views-analysis-digital/skys-limit-leo-pharma-rd-hub/
Novartis ranked top for corporate reputation in dermatologyNovartis has been ranked the top pharma company in dermatology in a corporate reputation survey of skin condition Share XNovartis ranked top for corporate reputation in dermatologyhttps://pharmaphorum.com/news/novartis-corporate-reputation-dermatology/
Leo and VCCP’s psoriasis campaign tops winners at PM Society AwardsTwo moving films highlighting serious health issues have won top honours at this year’s PM Society Awards in London. Share XLeo and VCCP’s psoriasis campaign tops winners at PM Society Awardshttps://pharmaphorum.com/news/leo-vccps-psoriasis-campaign-top-winners-pm-society-awards/
